Abstract
The known etiologies of acquired sensorineural hearing loss include acoustic trauma, physical trauma, ototoxicity, genetic predisposition, infections, Meniere’s disease, aging, and autoimmune disease. Treatments are directed at eliminating or managing the underlying disease process and aiding hearing with amplification. Rarely is it possible to improve unaided hearing after sensorineural loss except when the severe to profound level of loss is reached and cochlear implantation becomes an option. Autoimmune inner ear disease, however, is a treatable cause of sensorineural hearing loss and it is important for physicians and hearing health professionals to recognize that proper early diagnosis and management strategies may result in stabilization and possibly improvement in hearing.
Similar content being viewed by others
References and Recommended Reading
McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979, 88:585.
Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al.: Acute autoimmune sensorineural hearing loss associated with Chron’s disease. Am J Gastro 1998, 93(12):2565–2567.
Kumar BN, Walsh RM, Wilson PS, Carlin WV: Sensorineural hearing loss and ulcerative colitis. J Laryn Otol 1997, 111(3):277–278.
Okamura H, Ohtani I, Anzai T: The hearing loss in Wegener’s granulomatosis: relationship between hearing loss and serum ANCA. Aurus Nasus Larynx 1992, 19(1):1–6.
Heller U, Becker EW, Zenner HP, Berg PA: Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO 1998, 46(6):583–586.
Trune DR, Kempton JB, Mitchell CR, Hefeneider SH: Failure of heat shock protein 70 antibodies to alter cochlear function in mice. Hear Res 1998, 116(1-2):65–70.
Harris JP: Immunologic disorders affecting the ear. In Otolaryngology Head and Neck Surgery. Edited by Cummings CW et al. St. Louis: Mosby-Year Book Inc.; 1998:3172–3185.
Hirose K, Wener MH, Duckert LG: Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999, 109(11):1749–1754.
Ottaviani F, Cadoni G, Marinelli L, et al.: Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 1999, 109(7):1084–1087.
Yamawaki M, Ariga T, Gao Y, et al.: Sulfoglucuronsyl glycolipids as putative antigens for autoimmune inner ear disease. J Neuroimmunol 1998, 84(2):111–116.
Nair TS, Prieskorn DM, Miller JM, et al.: In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody. Hear Res 1997, 107(1-2):93–101.
Disher MJ, Ramakrishnan A, Nair TS, et al.: Human autoantibodies and monoclonal antibody to KHRI-3 bind to a phylogenetically conserved inner-ear-supporting cell antigen. Ann NY Acad Sci 1997, 830:253–265.
Nair TS, Prieskorn DM, Miller JM, et al.: KHRI-3 monoclonal antibody-induced damage to the inner ear: antibody staining of nascent scars. Hear Res 1999, 129(1-2):50–60.
Rauch SD: Serum antibodies against heat shock protein 70 in Meniere’s disease. Am J Otol 1995, 16:648.
Harris JP, Aframiam D: Role of autoimunity in contralateral delayed endolymphatic hydrops. Am J Otol 1994, 15:710.
Iwai H, Tomoda K, Sugiura K, et al.: T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac. Ann Otol Rhinol Laryngol 1999, 108(12):1146–1150.
Trune DR: Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg 1997, 117(5):504–508.
Wobig RJ, Kempton JB, Trune DR: Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse. Otolaryngol. Head Neck Surg 1999, 121(4):344–347.
Ruckenstein MJ, Sawar A, Hu L et al.: Effects of immunosuppression on the development of cochlear disease in the MRL-Fas(lpr) mouse. Laryngoscope 1999, 109(4):626–630.
Inoue Y, Kanzaki J, Ogawa K, et al.: Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss. Eur Arch Otorhinolaryngol 1998, 255(5):240–243.
Keithley EM, Chen MC, Linthicum F: Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 1998, 108(1):87–91.
Hoistad DL, Schachern PA, Paparella MM: Autoimmune sensorineural hearing loss: a human temporal bone study. Am J Otolaryn 1998, 19(1):33–39.
Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999, 109(7):1–17.
Sismanis A, Wise CM, Johnson GD: Methotrexate management of immune mediated cochleovestibular disorders Otolarlyngol Head Neck Surg 1997, 116:146–152.
Luetje CM, Berliner KI: Plasmaphoresis in autoimmnue inner ear disease: long-term follow-up. Am J Otol 1997, 18(5):572–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roland, J.T. Autoimmune inner ear disease. Curr Rheumatol Rep 2, 171–174 (2000). https://doi.org/10.1007/s11926-000-0058-y
Issue Date:
DOI: https://doi.org/10.1007/s11926-000-0058-y